22nd Century Secures $3.2 Million to Date in Warrant Exchange Transaction
December 04, 2023 07:07 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Dec. 04, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (the “Company”), a biotechnology company focused on utilizing advanced plant technologies to improve health...
22nd Century Appoints Larry Firestone as Chairman and CEO
November 29, 2023 07:07 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Nov. 29, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (“22nd Century” or the “Company”), a biotechnology company focused on utilizing advanced plant technologies...
22nd Century Group Enters into Agreement to Sell Hemp/Cannabis Franchise
November 27, 2023 16:44 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Nov. 27, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (the “Company” or “22nd Century”), a leading biotechnology company focused on utilizing advanced plant...
22nd Century Group Continues VLN® Expansion, Now Retailing in More Than 5,100 Stores
November 08, 2023 13:15 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Nov. 08, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and...
22nd Century Group (XXII) Expands Reduced Nicotine Content Tobacco IP with Latest Technology License
November 07, 2023 08:45 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Nov. 07, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and...
22nd Century Group (XXII) Reports Third Quarter 2023 Financial Results
November 06, 2023 07:30 ET
|
22nd Century Group, Inc
Third quarter 2023 net revenue of $17.8 millionExpanded VLN® availability to more than 4,550 stores in 19 statesProposed FDA menthol ban regulation now undergoing review at OMBGVB bulk ingredient...
22nd Century Group (XXII) Reduces Debt by $8.1 Million
October 25, 2023 09:00 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Oct. 25, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and...
22nd Century Announces Pricing of $5.25 Million Public Offering
October 17, 2023 09:15 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Oct. 17, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (the “Company”), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco,...
22nd Century Group (XXII) Adds 1,200 Drug Store Locations Selling VLN® in Five States
September 12, 2023 07:00 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Sept. 12, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and...
22nd Century Group Initiates Strategic Alternatives Process for Its Tobacco Assets
September 05, 2023 07:00 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Sept. 05, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ: XXII) (the “Company”) today announced that its Board of Directors, after consultation with its financial and legal...